Guidelines

AES Clinical Guidance in Development

• AES/Congress of Neurological Surgeons (CNS) Epilepsy Surgery Systematic Review and Guideline
  The draft protocol public comment period closed on November 20, 2022. Comments are currently under review, and the protocol will be posted on this page and submitted to PROSPERO once finalized.
• AES/American Clinical Neurophysiology Society (ACNS) Electrocorticography (ECoG) Systematic Review and Guideline
• Neurocritical Care Society (NCS)/AES Status Epilepticus Systematic Review and Guideline

AES Clinical Practice Guideline Development Manual (2020)
This manual outlines principles and processes intended to guide AES-led workgroups in the development of high-quality clinical guidance products consistent with broadly-accepted, evidence-based principles and processes appropriate to the needs of the epilepsy clinical community.

Evidence-Based Guidelines

• Practice Guideline Update Summary: Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New-onset Epilepsy
• Practice Guideline Update Summary: Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment-resistant Epilepsy
• Practice Guideline Summary: SUDEP Incidence Rates and Risk Factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society
• Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsy

• Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society
  • Guideline for Treatment of Prolonged Seizures in Children and Adults 
  • A Treatment Algorithm that Comprises Three Phases of Treatment 
• Evidence-based Guideline: Management of First Unprovoked Seizure in Adults
• Evidence-based Guideline: Evaluation and Management of Concussion in Sports
• Evidence-based Guideline: Vagus Nerve Stimulation for the Treatment of Epilepsy
• Evidence-based Guideline: Antiepileptic Drug Selection for People with HIV/AIDS